CSBR logo

CSBR

Champions Oncology Inc.

$5.87
-$0.17(-2.90%)
43
Overall
60
Value
27
Tech
42
Quality
How is this score calculated?
Market Cap
$95.14M
Volume
1.52K
52W Range
$5.50 - $9.63
Target Price
$12.00

Company Overview

Mkt Cap$95.14MPrice$5.87
Volume1.52KChange-2.90%
P/E Ratio20.2Open$6.04
Revenue$56.9MPrev Close$6.04
Net Income$4.7M52W Range$5.50 - $9.63
Div YieldN/ATarget$12.00
Overall43Value60
Quality42Technical27

No chart data available

About Champions Oncology Inc.

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Latest News

Champions Oncology Adds Director to Advance Data-Driven Strategy

The latest update is out from Champions Oncology ( ($CSBR) ). On March 24, 2026, Champions Oncology, Inc., a global oncology-focused research servi...

TipRanks Auto-Generated Newsdeska month ago
ABCD
1SymbolPriceChangeVol
2CSBR$5.87-2.9%1.52K
3
4
5
6

Get Champions Oncology Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.